Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

The management of chronic thromboembolic pulmonary hypertension has significantly changed over the last decade with the availability of both specific therapies and interventional treatments. In parallel, implantable pumps for intravenous administration of treprostinil have broadened the spectrum of...

Detaylı Bibliyografya
Asıl Yazarlar:	Regina Steringer-Mascherbauer, Charlotte Huber, Uwe Fröschl, Dagmar Engleder, Reinhold Függer, Maria Lummersdorfer, Ralf Lenhard, Martin Martinek
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	MDPI AG 2023-07-01
Seri Bilgileri:	Journal of Cardiovascular Development and Disease
Konular:	chronic thromboembolic pulmonary hypertension implantable pump intravenous treprostinil
Online Erişim:	https://www.mdpi.com/2308-3425/10/8/318

Benzer Materyaller

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
Yazar:: Pavel Jansa, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Long-term experience with implantable infusion pumps for intravenous treprostinil in pulmonary arterial hypertension—procedural safety and system-related complications
Yazar:: Regina Steringer-Mascherbauer, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
Yazar:: John W. Swisher, PhD, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
Yazar:: Jan C. Kamp, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
Yazar:: Marcin Kurzyna, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Venoarterial extracorporeal membrane oxygenation for vasoplegic shock after treprostinil refill of an implanted intravenous pump: a case report
Yazar:: Lucía Valencia, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure
Yazar:: Xiaofeng Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
Yazar:: Julia McSweeney, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
Yazar:: Lianghua Xiao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
Yazar:: Ibrahim Alissa, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia
Yazar:: Felix Rafael De Bie, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
Yazar:: Piotr Kędzierski, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
Yazar:: Enhuan Wei, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
Yazar:: Daniel Lachant, DO, ve diğerleri
Baskı/Yayın Bilgisi: (2025-05-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
Yazar:: Nicholas S. Hill, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function
Yazar:: Aleksandra Judina, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
Yazar:: Aparna C. Swaminathan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
Yazar:: Leslie A. Spikes, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
Yazar:: Helena Gauani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report
Yazar:: Jacqueline Brewer, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
Yazar:: Shelsey W. Johnson, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
Yazar:: Garance Kopp, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
Yazar:: Helena Gauani, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
Yazar:: Donna Steinbacher, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
Yazar:: Eun Woo Choi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
Yazar:: N. V. Marukyan, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
Yazar:: N M Danilov, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review
Yazar:: Burger CD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Direct prostacyclin transition in pediatric patients with pulmonary hypertension
Yazar:: Kelly Merrill, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Yazar:: Cheng Hong, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
Yazar:: Zheng-Wei Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation
Yazar:: Gil Bu Kang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
Yazar:: Diederik P. Staal, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension
Yazar:: Chen TX, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
Yazar:: Qi Jin, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease
Yazar:: HUANG Shenshen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
Yazar:: Amresh Raina, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
Yazar:: Jenna M. Faircloth, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
Yazar:: Jenna M. Faircloth, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Perioperative thromboembolism prophylaxis in children – is it necessary?
Yazar:: Izabela Pągowska-Klimek
Baskı/Yayın Bilgisi: (2020-08-01)